Procedures and Recommended Times in the Care Process of the Patient with Pancreatic Cancer: PAN-TIME Consensus Between Scientific Societies

Overview

Journal Clin Transl Oncol

Specialty Oncology

Date 2017 Jan 21

PMID 28105537

Citations 2

Authors

R Vera

A Ferrandez

C J Ferrer

C Flores

C Joaquin

S Lopez

T Martin

E Martin

M Marzo

A Sarrion

E Vaquero

A Zapatero

J Aparicio

Affiliations

Soon will be listed here.

Abstract

Purpose: Pancreatic cancer (PC) is a disease with bad prognosis. It is usually diagnosed at advanced stages and its treatment is complex. The aim of this consensus document was to provide recommendations by experts that would ameliorate PC diagnosis, reduce the time to treatment, and optimize PC management by interdisciplinary teams.

Methods: As a consensus method, we followed the modified Delphi methodology. A scientific committee of experts provided 40 statements that were submitted in two rounds to a panel of 87 specialists of 12 scientific societies.

Results: Agreement was reached for 39 of the 40 proposed statements (97.5%).

Conclusions: Although a screening of the asymptomatic population is not a feasible option, special attention to potential symptoms during primary care could ameliorate early diagnostic. It is especially important to decrease the period until diagnostic tests are performed. This consensus could improve survival in PC patients by decreasing the time to diagnose and time to treatment and by the implementation of multidisciplinary teams.

Citing Articles

[PAPPS Cancer Expert Group. Cancer Prevention Recommendations. 2020 PAPPS update].

Marzo-Castillejo M, Vela-Vallespin C, Bellas-Beceiro B, Bartolome-Moreno C, Gines-Diaz Y, Melus-Palazon E Aten Primaria. 2021; 52 Suppl 2:44-69.

PMID: 33388117 PMC: 7801199. DOI: 10.1016/j.aprim.2020.09.003.

From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer.

Munoz Martin A, Hidalgo M, Alvarez R, Arrazubi V, Martinez-Galan J, Salgado M J Cancer. 2018; 9(11):1978-1988.

PMID: 29896283 PMC: 5995948. DOI: 10.7150/jca.23716.

References

Pietryga J, Morgan D . Imaging preoperatively for pancreatic adenocarcinoma. J Gastrointest Oncol. 2015; 6(4):343-57. PMC: 4502157. DOI: 10.3978/j.issn.2078-6891.2015.024. View

Lee E, Lee J . Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol. 2014; 20(24):7864-77. PMC: 4069314. DOI: 10.3748/wjg.v20.i24.7864. View

Lemmens V, Bosscha K, Schelling G, Brenninkmeijer S, Coebergh J, de Hingh I . Improving outcome for patients with pancreatic cancer through centralization. Br J Surg. 2011; 98(10):1455-62. DOI: 10.1002/bjs.7581. View

de Mestier L, Danset J, Neuzillet C, Rebours V, Cros J, Soufir N . Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers. Endocr Relat Cancer. 2016; 23(10):T57-67. DOI: 10.1530/ERC-16-0269. View

Carrato A, Falcone A, Ducreux M, Valle J, Parnaby A, Djazouli K . A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs. J Gastrointest Cancer. 2015; 46(3):201-11. PMC: 4519613. DOI: 10.1007/s12029-015-9724-1. View

Chang D, Merrett N, Biankin A . Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem?. J Gastroenterol Hepatol. 2008; 23(7 Pt 1):1036-45. DOI: 10.1111/j.1440-1746.2008.05471.x. View

He X, Yuan Y . Advances in pancreatic cancer research: moving towards early detection. World J Gastroenterol. 2014; 20(32):11241-8. PMC: 4145762. DOI: 10.3748/wjg.v20.i32.11241. View

Witkowski E, Smith J, Ragulin-Coyne E, Ng S, Shah S, Tseng J . Is it worth looking? Abdominal imaging after pancreatic cancer resection: a national study. J Gastrointest Surg. 2011; 16(1):121-8. DOI: 10.1007/s11605-011-1699-z. View

Wolfgang C, Herman J, Laheru D, Klein A, Erdek M, Fishman E . Recent progress in pancreatic cancer. CA Cancer J Clin. 2013; 63(5):318-48. PMC: 3769458. DOI: 10.3322/caac.21190. View

10.

Vasen H, Ibrahim I, Guillen Ponce C, Slater E, Matthai E, Carrato A . Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers. J Clin Oncol. 2016; 34(17):2010-9. DOI: 10.1200/JCO.2015.64.0730. View

11.

Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E . European cancer mortality predictions for the year 2014. Ann Oncol. 2014; 25(8):1650-6. DOI: 10.1093/annonc/mdu138. View

12.

Lu C, Xu C, Wan X, Zhu H, Yu C, Li Y . Screening for pancreatic cancer in familial high-risk individuals: A systematic review. World J Gastroenterol. 2015; 21(28):8678-86. PMC: 4515849. DOI: 10.3748/wjg.v21.i28.8678. View

13.

Al-Hawary M, Francis I, Chari S, Fishman E, Hough D, Lu D . Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology. 2013; 270(1):248-60. DOI: 10.1148/radiol.13131184. View

14.

Eskander M, Bliss L, Tseng J . Pancreatic adenocarcinoma. Curr Probl Surg. 2016; 53(3):107-54. DOI: 10.1067/j.cpsurg.2016.01.001. View

15.

Jones J, Hunter D . Consensus methods for medical and health services research. BMJ. 1995; 311(7001):376-80. PMC: 2550437. DOI: 10.1136/bmj.311.7001.376. View

16.

Ducreux M, Cuhna A, Caramella C, Hollebecque A, Burtin P, Goere D . Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015; 26 Suppl 5:v56-68. DOI: 10.1093/annonc/mdv295. View

17.

Gooiker G, Lemmens V, Besselink M, Busch O, Bonsing B, Molenaar I . Impact of centralization of pancreatic cancer surgery on resection rates and survival. Br J Surg. 2014; 101(8):1000-5. DOI: 10.1002/bjs.9468. View